RS Oncology Announces First Patient Dosed in Phase 2 Clinical Study (MITOPE) Investigating RSO-021 for the Treatment of Malignant Pleural Mesothelioma and Metastatic Disease to the Lung
CAMBRIDGE, Mass. & LEICESTER, England–(BUSINESS WIRE)–#Lungcancer—RS Oncology (RSO), a clinical stage biotechnology company developing innovative... Read more.
Comvest Partners Expands Direct Lending Platform Senior Team with Hire of David Gibson as Managing Director
WEST PALM BEACH, Fla.–(BUSINESS WIRE)–#Comvest–Comvest Partners (“Comvest”), an operationally focused middle-market private investment firm,... Read more.
Data Demonstrating vMap’s Impact on Atrial Fibrillation Treatment Outcomes Unveiled at AF Symposium 2024
Dr. Jag Singh to Present vMap’s AI-Driven Innovation in a Spotlight Session BOSTON–(BUSINESS WIRE)–#arrhythmias–Vektor Medical, a pioneer... Read more.
Evriholder Products Acquires BASE4 Ventures
Combination enables further expansion of product lines, customers, and suppliers BREA, Calif.–(BUSINESS WIRE)–Evriholder Products LLC, a leading provider... Read more.
Janus Henderson Group plc Reports Fourth Quarter and Full-Year 2023 Results
Solid long-term investment performance, with 60%, 69%, and 71% of assets under management (“AUM”) outperforming relevant benchmarks on a three-, five-, and 10-year... Read more.
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024
JERSEY CITY, N.J.–(BUSINESS WIRE)–Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its fourth quarter... Read more.
MACOM Reports Fiscal First Quarter 2024 Financial Results
LOWELL, Mass.–(BUSINESS WIRE)–MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today... Read more.
Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024: Insights On 10 Current & Potential Proprietary Platforms, Company, Indication & Phase for 15 Drugs, and 14 Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024” report has been added... Read more.
Oklo Enters into Land Rights Agreement to Advance Deployment of Two Powerhouses in Southern Ohio
Agreement represents a significant step towards the deployment of two powerhouses, building on last year’s announcement of a non-binding MOU with SODI. The land... Read more.
Worldpay Begins Operating as Independent Company
Majority-Owner GTCR to work with Worldpay Management and FIS to Optimize Performance and Accelerate Growth As an Independent Company, Worldpay to Accelerate Investments... Read more.